about
Probenecid, a gout remedy, inhibits pannexin 1 channelsCombination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancyOnce-daily cefazolin and probenecid for skin and soft tissue infections1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivoPharmacokinetics and tolerability of oseltamivir combined with probenecid.Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function.Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovirStudies on the renal excretion of the acyl glucuronide, phenolic glucuronide and sulphate conjugates of diflunisalThe effect of probenecid on the renal tubular excretion of benzylpenicillinClinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patientsRenal handling of fleroxacin in rabbits, dogs, and humans.The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite FormationEffects of probenecid on the pharmacokinetics and elimination of acyclovir in humansProbenecid: antibacterial action against Neisseria gonorrhoeae and interaction with benzylpenicillinEffects of probenecid on the pharmacokinetics of allopurinol riboside.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Macrophages possess probenecid-inhibitable organic anion transporters that remove fluorescent dyes from the cytoplasmic matrix.A prelysosomal compartment sequesters membrane-impermeant fluorescent dyes from the cytoplasmic matrix of J774 macrophages.Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy.Drug-drug interactions involving membrane transporters in the human kidney.Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cellsLesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.The progressive ankylosis gene product ANK regulates extracellular ATP levels in primary articular chondrocytes.Migraine is a neuronal disease.The history and future of probenecid.Towards longitudinal mapping of extracellular pH in gliomas.Chemosensitization of Plasmodium falciparum by probenecid in vitro.Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits.Effects of urinary pH on renal interactions between probenecid and cefsulodin in rabbits.Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.Dose-dependent pharmacokinetics: emphasis on phase I metabolism.Effect of probenecid on the pharmacokinetics of cefmenoxime.The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretionMechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.Inhibitors of membrane transport system for organic anions block fura-2 excretion from PC12 and N2A cells.Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice.Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.Lack of probenecid effect on nonrenal excretion of ceftriaxone in anephric patients.
P2860
Q24647558-6299B955-5DD5-49F0-911B-4BD69E775FDDQ27005614-72C161DE-2A79-41D4-86D8-C79AF407DE09Q28245769-CF26F94C-416D-474F-927A-568374B5A811Q28368376-02822CEE-F63E-4965-9314-81545E40063EQ30370031-CC815F08-7340-43FB-842C-D015D71BED42Q33624852-989FE9A2-00ED-4A3F-93E3-EEC15E3F4DF1Q34109825-17B998E9-DDDD-4F67-88C1-AC0A2B15708BQ34403802-5839135B-4FBD-4937-8AE8-DC559A736D70Q34418304-3F470766-ACB4-4608-8333-9972ED7C1163Q35115039-AFB8E8A5-5825-4F59-B561-BCD302F002DFQ35245673-154170F6-ADE3-4DF2-B588-525E9090AF40Q35612898-C148E554-A1E9-47CF-86C6-9EC7CE3EA724Q35675773-14667BB7-D8FD-44CB-A7F4-70C08AA25C09Q35760485-7E5C8F62-D22B-4E9D-8E7D-2931D3E45CE0Q35815511-B923EF27-1C94-43E8-85EB-F74FE40A76A8Q36061821-3C44904D-4653-4B55-BA66-1DB14CAF7D01Q36217291-BEF1D2E9-2B0E-4246-9BE3-9B3A67F9ADBFQ36219515-C215286C-BAF2-4550-8E78-F6E9D62C63F9Q36505517-1752F0EC-F544-4864-B0E1-D6B5149E8526Q36543091-7C6AB5F1-EB32-4C5A-9122-850040E58816Q36799663-D023561D-A35E-4E5A-AAAD-A28D9D6DCB96Q37307966-2FEEAE0F-7D5C-4831-93C6-E8AC1617CFD4Q37689935-E37C9A2B-6AC4-4849-AFB9-7FDB1BAC785DQ37821333-85FD66A3-D8A5-4505-A823-1567649F38B8Q37936912-52013E4A-46CE-43C1-8791-665D3FC07AE0Q39545486-E78D187E-4433-4425-96C6-1374781D1100Q39776217-1E1AF7DF-877A-49CF-8FB3-7C103B7FCD9FQ39815074-1052BF9E-081D-476E-ABD1-F535CCA4D8F1Q39833516-3A6379D6-985E-456B-8978-FA3DC9892CACQ39849766-E1F818F0-ED66-4BCE-A73D-BF9BB2E86C7DQ39968960-8394D582-68E7-4F0F-95CE-B90135F85EF7Q40153504-2E3CC849-3B9A-4ADB-BABC-6136459BEB86Q41878247-EA0FD631-D2BC-40E0-A30F-1677321190DBQ41969706-2F8965CB-78A2-44CE-87BF-9D3E555B5F52Q42115623-BB95A880-B33D-4ECE-A166-A24AE449426CQ42820957-8E5C208B-9BC2-423A-9EE0-0D31C0011EACQ44222595-7AD73BE5-4B9B-4399-BD42-307C5CF2A5B8Q44737065-05CD5156-D28B-4C47-94F1-E4CD2C0912E1Q44741967-248F0A53-F1B2-49E2-9C84-623079F20003Q44945407-56032197-5AF8-442D-ADA5-BF5E6CD57B56
P2860
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Clinical pharmacokinetics of probenecid.
@en
type
label
Clinical pharmacokinetics of probenecid.
@en
prefLabel
Clinical pharmacokinetics of probenecid.
@en
P2093
P1476
Clinical pharmacokinetics of probenecid.
@en
P2093
P G Dayton
R F Cunningham
Z H Israili
P304
P356
10.2165/00003088-198106020-00004
P577
1981-03-01T00:00:00Z
P6179
1020115129